-
公开(公告)号:US20240095569A1
公开(公告)日:2024-03-21
申请号:US18465433
申请日:2023-09-12
申请人: Yale University
发明人: Max Hays , Michel Devoret
IPC分类号: G06N10/40
CPC分类号: G06N10/40
摘要: Techniques are described for detecting when background radiation has impacted a qubit without the need for additional hardware. In particular, a quantum system may operate readout hardware to read the state of a qubit in addition to operating the readout hardware to detect when an impact has occurred. Readouts from impacted qubits can then be ignored during error correction, and those qubits reset for subsequent operations. In some cases, a readout resonator coupled to a qubit can be implemented as a readout resonator with a high kinetic inductance.
-
公开(公告)号:US20240092759A1
公开(公告)日:2024-03-21
申请号:US18260744
申请日:2022-01-07
申请人: YALE UNIVERSITY
发明人: William L. Jorgensen
IPC分类号: C07D401/14 , A61K45/06 , A61P31/14 , C07D401/04 , C07D401/10 , C07D409/14 , C07D413/14 , C07D417/14
CPC分类号: C07D401/14 , A61K45/06 , A61P31/14 , C07D401/04 , C07D401/10 , C07D409/14 , C07D413/14 , C07D417/14
摘要: Provided herein are compounds of formula (I) or (I-A), which act as non-covalent inhibitors of SARS-CoV2 main protease (Mpro). The compounds of formula (I) or (I-A) are useful in treating COVID-19 infections, as well as reducing or ameliorating symptoms associated with COVID-19 infection.
-
33.
公开(公告)号:US20240087678A1
公开(公告)日:2024-03-14
申请号:US18465301
申请日:2023-09-12
申请人: Yale University
发明人: Manik Kuchroo , Smita Krishnaswamy
摘要: The present invention describes a CATCH assay for detecting cellular populations, biomarkers or biological interactions in a sample, and methods of use of the assay for identifying novel biomarkers of diseases and disorders and for diagnosing or treating diseases and disorders.
-
公开(公告)号:US20240081970A1
公开(公告)日:2024-03-14
申请号:US18241308
申请日:2023-09-01
申请人: Yale University
CPC分类号: A61F2/011 , A61F2/9517 , A61F2/0105
摘要: A medical device for retrieving an inferior vena cava filter from an inferior vena cava having a handle having a distal end, wherein a longitudinal axis is defined thereby; a grasping assembly coupled to the handle, wherein the grasping assembly comprises a grasper for grasping the inferior vena cava filter positioned within the inferior vena cava, and an articulation assembly coupled to the grasping assembly for causing the grasping assembly to move laterally with respect to the longitudinal axis of the handle. Methods of retrieving an inferior vena cava filter from an inferior vena cava are also disclosed.
-
公开(公告)号:US20240042063A1
公开(公告)日:2024-02-08
申请号:US18331904
申请日:2023-06-08
CPC分类号: A61K49/0056 , G01N33/84 , C07K7/06 , A61K47/65 , A61K47/42 , A61B5/0071 , A61K47/64 , C07K14/00 , G01N2033/0003
摘要: Provided herein are, inter alia, pH-triggered compounds and compositions comprising one or more peptides that are capable of inserting into a lipid bilayer below a certain pH. Treatment, imaging, diagnostic, and other uses of such compounds and compositions are also provided.
-
36.
公开(公告)号:US11890335B2
公开(公告)日:2024-02-06
申请号:US16651037
申请日:2018-09-27
发明人: Mark Mamula , Raymond A. Koski
CPC分类号: A61K39/001106 , A61P35/00 , A61K9/0019 , A61K2039/552 , A61K2039/55544 , A61K2039/55566 , A61K2039/55594 , A61K2039/6081
摘要: Disclosed herein are peptide-adjuvant pharmaceutical compositions and vaccine compositions that trigger long lasting natural anti-tumor antibodies. Such compositions may be used alone, or in combination with anti-cancer agents, chemotherapeutic agents, anti-PD therapy, chemotherapy, radiation therapy, and surgery, in the prevention and treatment of cancer.
-
公开(公告)号:US11883369B2
公开(公告)日:2024-01-30
申请号:US17663586
申请日:2022-05-16
申请人: Yale University
CPC分类号: A61K31/06 , A61K9/0053 , A61K9/501 , A61K9/5026 , A61K9/5042 , A61K9/5047 , A61K45/06
摘要: The present invention includes a low dose and sustained release formulation of a mitochondrial uncoupling agent The compositions of the invention are useful for preventing or treating a disease or disorder, such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, insulin resistance and/or diabetes, in a subject in need thereof.
-
公开(公告)号:US20240018169A1
公开(公告)日:2024-01-18
申请号:US18456819
申请日:2023-08-28
申请人: YALE UNIVERSITY
发明人: Anna Marie Pyle , Olga Fedorova , Erik Jagdmann , Michael Van Zandt , Lin Yuan , Albert DeBerardinis
IPC分类号: C07C243/38 , C07D213/30 , C07D239/26 , C07D307/52 , A61P31/10 , A61P31/04
CPC分类号: C07C243/38 , C07D213/30 , C07D239/26 , C07D307/52 , A61P31/10 , A61P31/04
摘要: The present invention provides compositions and methods for inhibiting group II intron splicing for treating or preventing a disease or disorder associated with an organism harboring an active group II intron. The present invention also provides compositions and methods for inhibiting group II intron splicing for inhibiting, preventing or reducing growth of an organism harboring an active group II intron.
-
公开(公告)号:US20230398037A1
公开(公告)日:2023-12-14
申请号:US18328231
申请日:2023-06-02
申请人: YALE UNIVERSITY
发明人: Daniel Wiznia , Jinlei Li , Claudia See
CPC分类号: A61J7/0053 , A61J1/22 , G16H20/13 , A61J2200/70 , A61J2200/30
摘要: Provided herein are patient-controlled oral liquid-medicine dispenser and deactivation systems. The system includes a dosing container having a defined volumetric capacity and a spillway adapted and configured to allow fluid in excess of the defined volumetric capacity to flow out of the dosing container; a sealed and tamperproof waste receptacle fluidly coupled to the dosing container, the waste receptacle adapted and configured to capture and prevent diversion of liquid medicine dispensed in excess of the defined volumetric capacity of the dosing container; and a suction apparatus extending between a lower region of the dosing container and outside of the dosing container. Also provided herein are methods of administering a medication using the system.
-
公开(公告)号:US11834460B2
公开(公告)日:2023-12-05
申请号:US17554831
申请日:2021-12-17
申请人: YALE UNIVERSITY
IPC分类号: C07D495/14 , C07D261/08 , C07D413/14 , C07D417/14 , A61P35/00
CPC分类号: C07D495/14 , A61P35/00 , C07D261/08
摘要: The description relates to imide-based compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.
-
-
-
-
-
-
-
-
-